RESUMO
We present a case of ureterovesical stenosis that developed in 2 of 203 renal transplant patients operated between 1997 and 2005 in our department. In the current case, an ureterovesical region tumor was identified 1.5 years after renal transplantation, while being operated for the correction of ureterovesical stenosis. This report sought to remind physicians about the possibility of a malignancy in patients with ureterovesical stenosis following renal transplantation.
Assuntos
Transplante de Rim/efeitos adversos , Neoplasias Ureterais/patologia , Neoplasias da Bexiga Urinária/patologia , Adulto , Antimetabólitos Antineoplásicos/uso terapêutico , Carcinoma de Células de Transição/diagnóstico por imagem , Carcinoma de Células de Transição/tratamento farmacológico , Carcinoma de Células de Transição/patologia , Desoxicitidina/análogos & derivados , Desoxicitidina/uso terapêutico , Humanos , Incidência , Masculino , Diálise Peritoneal Ambulatorial Contínua , Radiografia , Fatores de Tempo , Neoplasias Ureterais/diagnóstico por imagem , Neoplasias Ureterais/epidemiologia , Neoplasias da Bexiga Urinária/diagnóstico por imagem , Neoplasias da Bexiga Urinária/epidemiologia , GencitabinaRESUMO
The diagnosis and management of cholelithiasis in renal transplant patients are subjects of debate. The purpose of this study was to evaluate the outcomes of laparoscopic cholecystectomy in renal transplant patients with symptomatic gallstone disease. The records of 155 kidney transplant patients were reviewed, including 16 patients who, underwent laparoscopic cholecystectomy. Shortest interval time between transplantation and cholecystectomy was 2 years. Surgical morbidity were seen in two patients (12.5%) with no mortality and no graft loss. In conclusion, laparoscopic cholecystectomy can be performed safely with low morbidity in renal transplant patients who have symptomatic gallstone disease. The morbidity rate is comparable to nontransplant patients.